☰

Leah R. Hanson, Ph.D. - Publications

Affiliations: 
2001 University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Neuroscience Biology
Tree Info Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Drews HJ, Klein R, Lourhmati A, Buadze M, Schaeffeler E, Lang T, Seferyan T, Hanson LR, Frey Ii WH, de Vries TCGM, Thijssen-van Loosdregt IAEW, Gleiter CH, Schwab M, Danielyan L. Losartan Improves Memory, Neurogenesis and Cell Motility in Transgenic Alzheimer's Mice. Pharmaceuticals (Basel, Switzerland). 14. PMID 33672482 DOI: 10.3390/ph14020166  0.724
2021 Kosyakovsky J, Fine JM, Frey WH, Hanson LR. Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease. Pharmaceuticals (Basel, Switzerland). 14. PMID 33513737 DOI: 10.3390/ph14020095  0.6
2020 Rosenbloom M, Barclay T, Johnsen J, Erickson L, Svitak A, Pyle M, Frey W, Hanson LR. Double-Blind Placebo-Controlled Pilot Investigation of the Safety of a Single Dose of Rapid-Acting Intranasal Insulin in Down Syndrome. Drugs in R&D. PMID 32077057 DOI: 10.1007/s40268-020-00296-2  0.31
2020 Fine JM, Kosyakovsky J, Baillargeon AM, Tokarev JV, Cooner JM, Svitak AL, Faltesek KA, Frey WH, Hanson LR. Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non-disease-specific pathway of functional neurologic improvement. Brain and Behavior. e01536. PMID 31960628 DOI: 10.1002/Brb3.1536  0.619
2020 Kashyap B, Hanson LR, Frey Ii WH. Intranasal Insulin: a Treatment Strategy for Addiction. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 31898283 DOI: 10.1007/s13311-019-00822-4  0.71
2019 Fine JM, Stroebel BM, Faltesek KA, Terai K, Haase L, Knutzen KE, Kosyakovsky J, Bowe TJ, Fuller AK, Frey WH, Hanson LR. Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease. Neuroscience Letters. 714: 134567. PMID 31629033 DOI: 10.1016/J.Neulet.2019.134567  0.628
2019 Kosyakovsky J, Witthuhn BA, Svitak AL, Frey Ii WH, Hanson L, Fine J. Quantifying Intranasally Administered Deferoxamine in Rat Brain Tissue with Mass Spectrometry. Acs Chemical Neuroscience. PMID 31573798 DOI: 10.1021/Acschemneuro.9B00436  0.623
2019 Rautiola D, Maglalang PD, Cheryala N, Nelson KM, Georg GI, Fine JM, Svitak AL, Faltesek KA, Hanson LR, Mishra U, Coles LD, Cloyd JC, Siegel RA. Intranasal co-administration of a diazepam prodrug with a converting enzyme results in rapid absorption of diazepam in rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 30837282 DOI: 10.1124/Jpet.118.255943  0.554
2018 Dewji NN, Azar MR, Hanson LR, Frey Ii WH, Morimoto BH, Johnson D. Pharmacokinetics in Rat of P8, a Peptide Drug Candidate for the Treatment of Alzheimer's Disease: Stability and Delivery to the Brain. Journal of Alzheimer's Disease Reports. 2: 169-179. PMID 30480260 DOI: 10.3233/ADR-180078  0.724
2018 Maglalang PD, Rautiola D, Siegel RA, Fine JM, Hanson LR, Coles LD, Cloyd JC. Rescue therapies for seizure emergencies: New modes of administration. Epilepsia. PMID 30159892 DOI: 10.1111/Epi.14479  0.551
2017 Fine JM, Forsberg AC, Stroebel BM, Faltesek KA, Verden DR, Hamel KA, Raney EB, Crow JM, Haase LR, Knutzen KE, Kaczmarczek KD, Frey WH, Hanson LR. Intranasal deferoxamine affects memory loss, oxidation, and the insulin pathway in the streptozotocin rat model of Alzheimer's disease. Journal of the Neurological Sciences. 380: 164-171. PMID 28870559 DOI: 10.1016/J.Jns.2017.07.028  0.647
2017 Belur LR, Temme A, Podetz-Pedersen KM, Riedl M, Vulchanova L, Robinson N, Hanson LR, Kozarsky KF, Orchard PJ, Frey Ii WH, Low WC, McIvor RS. Intranasal AAV Mediated Gene Delivery and Expression of Human Iduronidase in the CNS: A Non-invasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I. Human Gene Therapy. PMID 28462595 DOI: 10.1089/Hum.2017.187  0.317
2016 Dhuria SV, Fine JM, Bingham D, Svitak AL, Burns RB, Baillargeon AM, Panter SS, Kazi AN, Frey WH, Hanson LR. Food consumption and activity levels increase in rats following intranasal Hypocretin-1. Neuroscience Letters. PMID 27264485 DOI: 10.1016/J.Neulet.2016.05.053  0.606
2016 Belur L, Buckvold M, Podetz-Pedersen KM, Riedl M, Vulchanova L, Hanson L, Fairbanks C, Kozarsky K, Frey WH, Low WC, Mclvor RS. 25. Intranasal Gene Delivery of AAV Iduronidase: An Effective and Non-Invasive Approach for Treatmentof CNS Disease in a Murine Model of MPS Type I Molecular Therapy. 24: S12. DOI: 10.1016/S1525-0016(16)32834-9  0.32
2015 Fine JM, Renner DB, Forsberg AC, Cameron RA, Galick BT, Le C, Conway PM, Stroebel BM, Frey WH, Hanson LR. Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation. Neuroscience Letters. 584: 362-7. PMID 25445365 DOI: 10.1016/J.Neulet.2014.11.013  0.666
2015 Belur L, Buckvold M, Podetz-Pedersen K, Riedl M, Vulchanova L, Hanson LR, Kozarsky K, Frey WH, Low WC, Fairbanks C, Scott McIvor R. 706. Non-Invasive Intranasal Administration of AAV9-Iduronidase Prevents Emergence of Neurologic Disease and Neurocognitive Dysfunction in a Murine Model of Mucopolysaccharidosis Type I Molecular Therapy. 23: S281. DOI: 10.1016/S1525-0016(16)34315-5  0.318
2015 Fine JM, Forsberg AC, Stroebel BM, Verden DR, Hamel KA, Raney EB, Frey WH, Hanson LR. P2-313: Intranasal deferoxamine prevents memory loss in the intracerebroventricular streptozotocin rat model of Alzheimer's disease Alzheimer's & Dementia. 11: P613-P614. DOI: 10.1016/J.Jalz.2015.06.855  0.617
2014 Fine JM, Forsberg AC, Renner DB, Faltesek KA, Mohan KG, Wong JC, Arneson LC, Crow JM, Frey WH, Hanson LR. Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinson׳s disease. Brain Research. 1574: 96-104. PMID 24928620 DOI: 10.1016/J.Brainres.2014.05.048  0.595
2014 Francis G, Martinez J, Liu W, Nguyen T, Ayer A, Fine J, Zochodne D, Hanson LR, Frey WH, Toth C. Intranasal insulin ameliorates experimental diabetic neuropathy (Diabetes (2009) 58 (934-945) DOI: 10.2337/db08-1287) Diabetes. 63: 1817. PMID 24757204 DOI: 10.2337/Db14-Rt05A  0.532
2013 Hanson LR, Fine JM, Svitak AL, Faltesek KA. Intranasal administration of CNS therapeutics to awake mice. Journal of Visualized Experiments : Jove. PMID 23608783 DOI: 10.3791/4440  0.639
2012 Hanson LR, Fine JM, Renner DB, Svitak AL, Burns RB, Nguyen TM, Tuttle NJ, Marti DL, Panter SS, Frey WH. Intranasal delivery of deferoxamine reduces spatial memory loss in APP/PS1 mice. Drug Delivery and Translational Research. 2: 160-8. PMID 25786865 DOI: 10.1007/S13346-011-0050-2  0.677
2012 Fine JM, Baillargeon AM, Renner DB, Hoerster NS, Tokarev J, Colton S, Pelleg A, Andrews A, Sparley KA, Krogh KM, Frey WH, Hanson LR. Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1α, and phosphorylates GSK3β in P301L tau transgenic mice. Experimental Brain Research. 219: 381-90. PMID 22547371 DOI: 10.1007/S00221-012-3101-0  0.636
2012 Hanson LR, Fine JM, Hoekman JD, Nguyen TM, Burns RB, Martinez PM, Pohl J, Frey WH. Intranasal delivery of growth differentiation factor 5 to the central nervous system. Drug Delivery. 19: 149-54. PMID 22353012 DOI: 10.3109/10717544.2012.657720  0.608
2012 Gomez D, Martinez JA, Hanson LR, Frey WH, Toth CC. Intranasal treatment of neurodegenerative diseases and stroke. Frontiers in Bioscience (Scholar Edition). 4: 74-89. PMID 22202044 DOI: 10.2741/252  0.3
2011 Hanson LR, Hafez D, Svitak AL, Burns RB, Li X, Frey WH, Marr RA. Intranasal phosphoramidon increases beta-amyloid levels in wild-type and NEP/NEP2-deficient mice. Journal of Molecular Neuroscience : Mn. 43: 424-7. PMID 20941644 DOI: 10.1007/S12031-010-9460-8  0.388
2010 Danielyan L, Klein R, Hanson LR, Buadze M, Schwab M, Gleiter CH, Frey WH. Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease. Rejuvenation Research. 13: 195-201. PMID 20370487 DOI: 10.1089/rej.2009.0944  0.313
2010 Fine JM, Baillargeon AM, Tokarev JV, Cooner JM, Smith TJ, Svitak AL, Krogh K, Thornton LT, Frey WH, Hanson LR. P1-129: Intranasal deferoxamine improves memory and decreases GSK3β activity in C57 mice Alzheimer's & Dementia. 6: S211-S211. DOI: 10.1016/J.Jalz.2010.05.678  0.592
2009 Francis G, Martinez J, Liu W, Nguyen T, Ayer A, Fine J, Zochodne D, Hanson LR, Frey WH, Toth C. Intranasal insulin ameliorates experimental diabetic neuropathy. Diabetes. 58: 934-45. PMID 19136650 DOI: 10.2337/Db08-1287  0.597
2009 Fine JM, Renner D, Baillargeon A, Hoerster N, Tokarev J, Colton S, Pelleg A, Andrews A, Sparley K, Frey WH, Hanson LR. P2-199: Intranasal deferoxamine improves radial arm water maze performance in P301L tau transgenic mice Alzheimer's & Dementia. 5: P319-P319. DOI: 10.1016/J.Jalz.2009.04.511  0.588
2008 Hanson LR, Frey WH. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. Bmc Neuroscience. 9: S5. PMID 19091002 DOI: 10.1186/1471-2202-9-S3-S5  0.405
2008 Francis GJ, Martinez JA, Liu WQ, Xu K, Ayer A, Fine J, Tuor UI, Glazner G, Hanson LR, Frey WH, Toth C. Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy. Brain : a Journal of Neurology. 131: 3311-34. PMID 19015157 DOI: 10.1093/Brain/Awn288  0.599
2007 Hanson LR, Frey WH. Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 2: 81-6. PMID 18040829 DOI: 10.1007/s11481-006-9039-x  0.357
2007 Hanson LR, Fine JM, Tuttle NJ, Marti DL, Matthews RB, Nguyen TM, Svitak AL, Panter SS, Frey WH. O2-05-01: Intranasally administered deferoxamine improves spatial memory in APP/PS1 mice Alzheimer's & Dementia. 3: S195-S195. DOI: 10.1016/J.Jalz.2007.04.017  0.586
1998 Hanson LR, Sorensen PW, Cohen Y. Sex pheromones and amino acids evoke distinctly different spatial patterns of electrical activity in the goldfish olfactory bulb. Annals of the New York Academy of Sciences. 855: 521-4. PMID 10049233 DOI: 10.1111/J.1749-6632.1998.Tb10619.X  0.458
Show low-probability matches.